Latest News and Events
Filter by
Selections
June 25, 2021
Arrowhead Presents Preclinical Data on ARO-DUX4 at FSHD Society International Research Congress
Read MoreJune 23, 2021
Arrowhead Presents Positive Interim Clinical Data on ARO-HSD Treatment in Patients with Suspected NASH at EASL International Liver Congress
Read MoreJune 21, 2021
Arrowhead Pharmaceuticals and Horizon Therapeutics Announce Collaboration to Develop RNAi Therapeutic for Uncontrolled Gout
Read MoreJune 21, 2021
Arrowhead Pharmaceuticals and Horizon Therapeutics Announce Collaboration to Develop RNAi Therapeutic for Uncontrolled Gout
Read MoreJune 3, 2021